Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022). PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Frontiers in oncology, 12, 819128. https://doi.org/10.3389/fonc.2022.819128
Chicago-Zitierstil (17. Ausg.)Peng, Yan, Yuanyuan Wang, Cheng Zhou, Wuxuan Mei, und Changchun Zeng. "PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?" Frontiers in Oncology 12 (2022): 819128. https://doi.org/10.3389/fonc.2022.819128.
MLA-Zitierstil (9. Ausg.)Peng, Yan, et al. "PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?" Frontiers in Oncology, vol. 12, 2022, p. 819128, https://doi.org/10.3389/fonc.2022.819128.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.